Inovio Pharmaceuticals Inc
F:GBM
Inovio Pharmaceuticals Inc
F:GBM
Price:
0.583
EUR
4.67%
Market Cap:
€40.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Inovio Pharmaceuticals Inc
F:GBM
|
US |
|
BRP Inc
TSX:DOO
|
CA |
|
X
|
Xiamen International Port Co Ltd
F:XRG
|
CN |
Wall St Price Targets
GBM Price Targets Summary
Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc
Wall Street analysts forecast GBM stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for GBM is 5.972 EUR with a low forecast of 3.1 EUR and a high forecast of 10.744 EUR.
Lowest Forecast
Price Target
3.1
EUR
432% Upside
Average Forecast
Price Target
5.972
EUR
924% Upside
Highest Forecast
Price Target
10.744
EUR
1 743% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GBM's stock price target?
Price Target
5.972
EUR
5.972
EUR
According to Wall Street analysts, the average 1-year price target for GBM is 5.972 EUR with a low forecast of 3.1 EUR and a high forecast of 10.744 EUR.
What is the Revenue forecast for Inovio Pharmaceuticals Inc?
Projected CAGR
163%
163%
Over the last 13 years, the compound annual growth rate for Revenue has been -27%. The projected CAGR for the next 8 years is 163%.
